RSV Vaccine For Adults Gives Long-Term Protection, GSK Says After Late-Stage Trial
Drugmaker GSK said Wednesday its RSV vaccine gave long-term protection in older adults after a single shot, according to results from its late stage clinical trial, promising news for efforts to combat the common and potentially lethal infection. GSK said the shot, which is designed to protect…
#drugmakergsk #rsv #gsk #arexvy #tonywood #pfizer #abrysvo #fda #globalsouth #quartz